Details for: DEK

Gene ID: 7913

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: DEK

Ensembl ID: ENSG00000124795

Description: DEK proto-oncogene

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • common myeloid progenitor CL0000049
    CSI 94.59
    rCSI 76.48%
    PRS 9.09
  • granulocyte monocyte progenitor cell CL0000557
    CSI 93.55
    rCSI 81%
    PRS 10.25
  • hematopoietic stem cell CL0000037
    CSI 93.39
    rCSI 62.08%
    PRS 10.99
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 90.5
    rCSI 81.72%
    PRS 8.14
  • pro-B cell CL0000826
    CSI 85.83
    rCSI 71.07%
    PRS 9.21
  • fallopian tube secretory epithelial cell CL4030006
    CSI 80.57
    rCSI 77.56%
    PRS 9.52
  • keratinocyte CL0000312
    CSI 70.6
    rCSI 59.18%
    PRS 11
  • transit amplifying cell of colon CL0009011
    CSI 66.95
    rCSI 78.63%
    PRS 10.93
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 66.76
    rCSI 77.1%
    PRS 8.15
  • stem cell CL0000034
    CSI 65.41
    rCSI 63.07%
    PRS 6.04
  • common dendritic progenitor CL0001029
    CSI 62.36
    rCSI 78.27%
    PRS 11.75
  • fraction A pre-pro B cell CL0002045
    CSI 56.26
    rCSI 64.4%
    PRS 19.03
  • radial glial cell CL0000681
    CSI 54.18
    rCSI 75.26%
    PRS 9.51
  • promyelocyte CL0000836
    CSI 53.47
    rCSI 77.12%
    PRS 12.87
  • group 3 innate lymphoid cell CL0001071
    CSI 51.4
    rCSI 38.62%
    PRS 9.52
  • early lymphoid progenitor CL0000936
    CSI 50.87
    rCSI 44.68%
    PRS 10.34
  • promonocyte CL0000559
    CSI 47.55
    rCSI 81.47%
    PRS 12.36
  • mesodermal cell CL0000222
    CSI 46.16
    rCSI 55.41%
    PRS 9.13
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 44.03
    rCSI 33.93%
    PRS 8.31
  • epithelial cell of lung CL0000082
    CSI 41.87
    rCSI 34.71%
    PRS 8.73
  • ciliated epithelial cell CL0000067
    CSI 41.67
    rCSI 36.64%
    PRS 6.66
  • extravillous trophoblast CL0008036
    CSI 41.46
    rCSI 51.29%
    PRS 8.07
  • intestinal epithelial cell CL0002563
    CSI 39.97
    rCSI 41.77%
    PRS 9.7
  • enteric smooth muscle cell CL0002504
    CSI 38.04
    rCSI 54.29%
    PRS 10.4
  • placental villous trophoblast CL2000060
    CSI 36.75
    rCSI 56.78%
    PRS 8.61
  • transit amplifying cell CL0009010
    CSI 35.49
    rCSI 54.28%
    PRS 14.95
  • neural crest cell CL0011012
    CSI 34.51
    rCSI 27.28%
    PRS 6.33
  • double negative thymocyte CL0002489
    CSI 32.91
    rCSI 22.88%
    PRS 10.78
  • large pre-B-II cell CL0000957
    CSI 32.65
    rCSI 93.22%
    PRS 16.2
  • conventional dendritic cell CL0000990
    CSI 31.31
    rCSI 26.13%
    PRS 28.23
  • colon epithelial cell CL0011108
    CSI 30.77
    rCSI 32.23%
    PRS 8.55
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 29.51
    rCSI 30.08%
    PRS 13.12
  • lung ciliated cell CL1000271
    CSI 28.91
    rCSI 33.43%
    PRS 6.74
  • Hofbauer cell CL3000001
    CSI 27.68
    rCSI 52.25%
    PRS 11.41
  • microcirculation associated smooth muscle cell CL0008035
    CSI 24.94
    rCSI 72.21%
    PRS 10.42
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 23.77
    rCSI 64.07%
    PRS 11.88
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 22.93
    rCSI 89.25%
    PRS 15.23
  • forebrain radial glial cell CL0013000
    CSI 22.77
    rCSI 73.06%
    PRS 13.67
  • stromal cell of ovary CL0002132
    CSI 22.32
    rCSI 61.34%
    PRS 15.3
  • precursor B cell CL0000817
    CSI 22.26
    rCSI 19.5%
    PRS 12.32
  • plasmablast CL0000980
    CSI 22.04
    rCSI 17.34%
    PRS 10.96
  • mesangial cell CL0000650
    CSI 21.92
    rCSI 89.34%
    PRS 12.9
  • germinal center B cell CL0000844
    CSI 21.91
    rCSI 65.35%
    PRS 23.7
  • IgA plasma cell CL0000987
    CSI 21.85
    rCSI 22.37%
    PRS 17.34
  • pancreatic ductal cell CL0002079
    CSI 21.62
    rCSI 42.06%
    PRS 9.37
  • pancreatic A cell CL0000171
    CSI 19.77
    rCSI 20.71%
    PRS 9.8
  • CD4-positive helper T cell CL0000492
    CSI 19.56
    rCSI 14.8%
    PRS 12.79
  • colon goblet cell CL0009039
    CSI 19.41
    rCSI 46.14%
    PRS 13.82
  • mammary gland epithelial cell CL0002327
    CSI 18.45
    rCSI 64.72%
    PRS 16.69
  • epithelial cell CL0000066
    CSI 18.4
    rCSI 28.27%
    PRS 13.2
  • multi-ciliated epithelial cell CL0005012
    CSI 17.79
    rCSI 17.76%
    PRS 7.9
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 17.73
    rCSI 42.67%
    PRS 14.66
  • progenitor cell CL0011026
    CSI 17.65
    rCSI 37.53%
    PRS 16.81
  • common lymphoid progenitor CL0000051
    CSI 17.17
    rCSI 22.95%
    PRS 17.63
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 16.39
    rCSI 19.8%
    PRS 10.83
  • erythroblast CL0000765
    CSI 15.89
    rCSI 42.18%
    PRS 15.44
  • endothelial cell of placenta CL0009092
    CSI 15.48
    rCSI 76.29%
    PRS 12.52
  • tendon cell CL0000388
    CSI 15.45
    rCSI 40.15%
    PRS 26.48
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 15.39
    rCSI 79.44%
    PRS 18.47
  • hematopoietic precursor cell CL0008001
    CSI 15.03
    rCSI 15.46%
    PRS 15.05
  • thymocyte CL0000893
    CSI 15
    rCSI 53.31%
    PRS 29.35
  • primitive red blood cell CL0002355
    CSI 14.8
    rCSI 79.87%
    PRS 17.48
  • epithelial cell of lower respiratory tract CL0002632
    CSI 13.64
    rCSI 10.58%
    PRS 8.78
  • mucous neck cell CL0000651
    CSI 13.41
    rCSI 19.33%
    PRS 14.84
  • intestine goblet cell CL0019031
    CSI 13.35
    rCSI 11.85%
    PRS 9.2
  • eosinophil CL0000771
    CSI 13.16
    rCSI 86.39%
    PRS 24.12
  • basophil mast progenitor cell CL0002028
    CSI 13.15
    rCSI 70.15%
    PRS 34.19
  • transit amplifying cell of small intestine CL0009012
    CSI 13.06
    rCSI 57.32%
    PRS 17.19
  • conjunctival epithelial cell CL1000432
    CSI 12.95
    rCSI 19.78%
    PRS 9.22
  • glioblast CL0000030
    CSI 12.1
    rCSI 19.3%
    PRS 7.92
  • transitional stage B cell CL0000818
    CSI 12.07
    rCSI 39.51%
    PRS 27.12
  • intermediate monocyte CL0002393
    CSI 11.99
    rCSI 18.09%
    PRS 9.06
  • peripheral nervous system neuron CL2000032
    CSI 11.73
    rCSI 15.99%
    PRS 8.25
  • lung endothelial cell CL1001567
    CSI 11.69
    rCSI 27.25%
    PRS 22.59
  • glandular epithelial cell CL0000150
    CSI 11.65
    rCSI 30.66%
    PRS 18.03
  • myeloid leukocyte CL0000766
    CSI 11.54
    rCSI 10.64%
    PRS 9.37
  • pancreatic D cell CL0000173
    CSI 11.43
    rCSI 11.25%
    PRS 9.99
  • M cell of gut CL0000682
    CSI 11.27
    rCSI 11.98%
    PRS 16.42
  • type EC enteroendocrine cell CL0000577
    CSI 11.22
    rCSI 39.82%
    PRS 15.09
  • paneth cell of epithelium of small intestine CL1000343
    CSI 11.1
    rCSI 31.11%
    PRS 14.28
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 10.94
    rCSI 66.17%
    PRS 20.91
  • erythroid progenitor cell CL0000038
    CSI 10.9
    rCSI 62.47%
    PRS 14.46
  • interstitial cell of Cajal CL0002088
    CSI 10.27
    rCSI 13.08%
    PRS 10.7
  • mature B cell CL0000785
    CSI 10.24
    rCSI 8.9%
    PRS 11.36
  • respiratory hillock cell CL4030023
    CSI 10.12
    rCSI 18.05%
    PRS 15.68
  • myeloid dendritic cell, human CL0001057
    CSI 9.97
    rCSI 56.11%
    PRS 29.27
  • T-helper 17 cell CL0000899
    CSI 9.82
    rCSI 7.8%
    PRS 16.21
  • mature T cell CL0002419
    CSI 9.8
    rCSI 7.62%
    PRS 13.23
  • dendritic cell, human CL0001056
    CSI 9.68
    rCSI 14.87%
    PRS 10.74
  • alternatively activated macrophage CL0000890
    CSI 9.51
    rCSI 11.95%
    PRS 14.08
  • secretory cell CL0000151
    CSI 9.28
    rCSI 9.68%
    PRS 9.44
  • memory B cell CL0000787
    CSI 9.26
    rCSI 9.14%
    PRS 37.21
  • tuft cell of colon CL0009041
    CSI 9.2
    rCSI 21.43%
    PRS 20.63
  • pancreatic stellate cell CL0002410
    CSI 9.07
    rCSI 52.8%
    PRS 13.85
  • myeloid dendritic cell CL0000782
    CSI 8.76
    rCSI 12.7%
    PRS 13.57
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 8.7
    rCSI 17.34%
    PRS 15.41
  • respiratory basal cell CL0002633
    CSI 8.66
    rCSI 8.97%
    PRS 10.82
  • colon macrophage CL0009038
    CSI 8.64
    rCSI 39.92%
    PRS 19.57
  • goblet cell CL0000160
    CSI 8.28
    rCSI 7.82%
    PRS 9.6
  • dendritic cell CL0000451
    CSI 8.27
    rCSI 10.19%
    PRS 30.25
  • astrocyte of the cerebral cortex CL0002605
    CSI -10.4
    rCSI -23.3%
    PRS 5.7%
  • renal principal cell CL0005009
    CSI -9.7
    rCSI -25.1%
    PRS 12.8%
  • renal beta-intercalated cell CL0002201
    CSI -6.7
    rCSI -15.9%
    PRS 11.3%
  • cardiac neuron CL0010022
    CSI -4.1
    rCSI -13.2%
    PRS 6.6%
  • alveolar type 1 fibroblast cell CL4028004
    CSI -4.0
    rCSI -4.3%
    PRS 10.6%
  • alpha-beta T cell CL0000789
    CSI -3.7
    rCSI -4.3%
    PRS 13.1%
  • regular ventricular cardiac myocyte CL0002131
    CSI -3.3
    rCSI -20.8%
    PRS 7.3%
  • lung neuroendocrine cell CL1000223
    CSI -3.0
    rCSI -4.4%
    PRS 10.6%
  • renal interstitial pericyte CL1001318
    CSI -2.8
    rCSI -7.8%
    PRS 9.1%
  • fibroblast of cardiac tissue CL0002548
    CSI -2.6
    rCSI -12.5%
    PRS 5.8%
  • cerebral cortex endothelial cell CL1001602
    CSI -2.4
    rCSI -4.1%
    PRS 7.0%
  • brush cell CL0002204
    CSI -2.3
    rCSI -4.5%
    PRS 25.3%
  • sncg GABAergic cortical interneuron CL4023015
    CSI -2.1
    rCSI -3.4%
    PRS 6.1%
  • stratified epithelial cell CL0000079
    CSI -1.8
    rCSI -11.2%
    PRS 40.0%
  • platelet CL0000233
    CSI -1.6
    rCSI -6.7%
    PRS 22.1%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI -1.3
    rCSI -3.5%
    PRS 9.1%
  • retinal pigment epithelial cell CL0002586
    CSI -1.3
    rCSI -2.6%
    PRS 9.9%
  • Kupffer cell CL0000091
    CSI -1.2
    rCSI -2.7%
    PRS 8.9%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI -1.0
    rCSI -2.5%
    PRS 26.8%
  • colonocyte CL1000347
    CSI -0.7
    rCSI -1.0%
    PRS 12.6%
  • lung pericyte CL0009089
    CSI -0.7
    rCSI -1.9%
    PRS 11.0%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI -0.7
    rCSI -0.7%
    PRS 14.6%
  • VIP GABAergic cortical interneuron CL4023016
    CSI -0.4
    rCSI -0.5%
    PRS 5.3%
  • myoepithelial cell CL0000185
    CSI -0.3
    rCSI -0.8%
    PRS 11.5%
  • pulmonary artery endothelial cell CL1001568
    CSI -0.2
    rCSI -0.3%
    PRS 14.1%
  • neuroendocrine cell CL0000165
    CSI -0.2
    rCSI -0.6%
    PRS 19.4%
  • tracheobronchial smooth muscle cell CL0019019
    CSI -0.1
    rCSI -0.2%
    PRS 12.2%
  • parietal epithelial cell CL1000452
    CSI 0.0
    rCSI 0.1%
    PRS 8.4%
  • exhausted T cell CL0011025
    CSI 0.1
    rCSI 1.8%
    PRS 39.4%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.1
    rCSI 0.4%
    PRS 5.8%
  • pulmonary alveolar type 1 cell CL0002062
    CSI 0.2
    rCSI 1.0%
    PRS 12.6%
  • nasal mucosa goblet cell CL0002480
    CSI 0.2
    rCSI 0.3%
    PRS 13.7%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 0.2
    rCSI 2.4%
    PRS 38.7%
  • amacrine cell CL0000561
    CSI 0.2
    rCSI 0.7%
    PRS 7.5%
  • sst GABAergic cortical interneuron CL4023017
    CSI 0.2
    rCSI 0.3%
    PRS 5.8%
  • immature innate lymphoid cell CL0001082
    CSI 0.2
    rCSI 7.5%
    PRS 80.3%
  • double negative T regulatory cell CL0011024
    CSI 0.2
    rCSI 4.6%
    PRS 56.6%
  • endocardial cell CL0002350
    CSI 0.3
    rCSI 1.3%
    PRS 12.8%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.3
    rCSI 0.9%
    PRS 6.3%
  • basal cell of epidermis CL0002187
    CSI 0.3
    rCSI 0.5%
    PRS 10.3%
  • epithelial cell of esophagus CL0002252
    CSI 0.3
    rCSI 3.0%
    PRS 34.8%
  • cytotoxic T cell CL0000910
    CSI 0.3
    rCSI 1.8%
    PRS 13.8%
  • centrilobular region hepatocyte CL0019029
    CSI 0.3
    rCSI 0.9%
    PRS 15.3%
  • memory T cell CL0000813
    CSI 0.4
    rCSI 0.7%
    PRS 20.9%
  • S cone cell CL0003050
    CSI 0.4
    rCSI 1.6%
    PRS 6.9%
  • cone retinal bipolar cell CL0000752
    CSI 0.4
    rCSI 5.5%
    PRS 39.3%
  • pancreatic epsilon cell CL0005019
    CSI 0.4
    rCSI 2.1%
    PRS 22.4%
  • squamous epithelial cell CL0000076
    CSI 0.5
    rCSI 1.1%
    PRS 11.9%
  • cardiac endothelial cell CL0010008
    CSI 0.5
    rCSI 1.9%
    PRS 8.7%
  • alveolar adventitial fibroblast CL4028006
    CSI 0.5
    rCSI 0.8%
    PRS 9.2%
  • endothelial cell of arteriole CL1000412
    CSI 0.5
    rCSI 2.9%
    PRS 31.4%
  • forebrain neuroblast CL1000042
    CSI 0.6
    rCSI 5.9%
    PRS 75.2%
  • retinal ganglion cell CL0000740
    CSI 0.6
    rCSI 1.2%
    PRS 6.6%
  • mucus secreting cell CL0000319
    CSI 0.6
    rCSI 0.9%
    PRS 11.9%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.6
    rCSI 2.9%
    PRS 12.1%
  • OFF-bipolar cell CL0000750
    CSI 0.6
    rCSI 0.8%
    PRS 15.4%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.6
    rCSI 2.0%
    PRS 38.1%
  • vasa recta ascending limb cell CL1001131
    CSI 0.6
    rCSI 2.8%
    PRS 36.5%
  • epithelial cell of proximal tubule CL0002306
    CSI 0.6
    rCSI 1.5%
    PRS 9.3%
  • Bergmann glial cell CL0000644
    CSI 0.6
    rCSI 0.9%
    PRS 9.6%
  • macroglial cell CL0000126
    CSI 0.7
    rCSI 1.7%
    PRS 14.1%
  • vasa recta descending limb cell CL1001285
    CSI 0.7
    rCSI 5.3%
    PRS 38.8%
  • smooth muscle cell of the pulmonary artery CL0002591
    CSI 0.7
    rCSI 5.1%
    PRS 39.1%
  • hepatic stellate cell CL0000632
    CSI 0.7
    rCSI 2.6%
    PRS 7.9%
  • endothelial cell of periportal hepatic sinusoid CL0019021
    CSI 0.7
    rCSI 3.3%
    PRS 28.3%
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 0.7
    rCSI 2.3%
    PRS 15.5%
  • helper T cell CL0000912
    CSI 0.8
    rCSI 1.1%
    PRS 13.1%
  • tracheal goblet cell CL1000329
    CSI 0.8
    rCSI 1.6%
    PRS 18.7%
  • lung microvascular endothelial cell CL2000016
    CSI 0.8
    rCSI 15.0%
    PRS 30.6%
  • glycinergic amacrine cell CL4030028
    CSI 0.8
    rCSI 2.0%
    PRS 9.6%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 0.8
    rCSI 2.0%
    PRS 5.3%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 0.8
    rCSI 1.5%
    PRS 5.4%
  • type L enteroendocrine cell CL0002279
    CSI 0.9
    rCSI 1.7%
    PRS 18.2%
  • muscle cell CL0000187
    CSI 0.9
    rCSI 1.9%
    PRS 22.0%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 0.9
    rCSI 1.5%
    PRS 5.4%
  • small pre-B-II cell CL0000954
    CSI 0.9
    rCSI 0.9%
    PRS 19.5%
  • retinal bipolar neuron CL0000748
    CSI 0.9
    rCSI 1.7%
    PRS 6.8%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.0
    rCSI 7.7%
    PRS 9.7%
  • lung secretory cell CL1000272
    CSI 1.0
    rCSI 2.4%
    PRS 8.5%
  • intestinal tuft cell CL0019032
    CSI 1.0
    rCSI 1.6%
    PRS 10.6%
  • smooth muscle cell of prostate CL1000487
    CSI 1.0
    rCSI 6.1%
    PRS 42.0%
  • syncytiotrophoblast cell CL0000525
    CSI 1.1
    rCSI 3.0%
    PRS 18.3%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 1.1
    rCSI 1.9%
    PRS 14.0%
  • epithelial cell of urethra CL1000296
    CSI 1.1
    rCSI 27.4%
    PRS 30.7%
  • mononuclear phagocyte CL0000113
    CSI 1.1
    rCSI 2.5%
    PRS 10.1%
  • vascular leptomeningeal cell CL4023051
    CSI 1.1
    rCSI 2.0%
    PRS 6.8%
  • IgG plasma cell CL0000985
    CSI 1.2
    rCSI 1.4%
    PRS 16.0%
  • paneth cell of colon CL0009009
    CSI 1.2
    rCSI 11.7%
    PRS 27.0%
  • tissue-resident macrophage CL0000864
    CSI 1.2
    rCSI 5.8%
    PRS 21.1%
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 1.3
    rCSI 3.2%
    PRS 8.6%
  • peptic cell CL0000155
    CSI 1.3
    rCSI 12.3%
    PRS 28.1%
  • luminal cell of prostate epithelium CL0002340
    CSI 1.3
    rCSI 6.9%
    PRS 16.7%
  • enteroendocrine cell of colon CL0009042
    CSI 1.3
    rCSI 6.1%
    PRS 24.9%
  • endothelial cell of venule CL1000414
    CSI 1.4
    rCSI 12.0%
    PRS 41.6%
  • tracheobronchial serous cell CL0019001
    CSI 1.4
    rCSI 5.9%
    PRS 17.9%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 1.4
    rCSI 2.0%
    PRS 8.6%
  • retina horizontal cell CL0000745
    CSI 1.5
    rCSI 2.2%
    PRS 8.6%
  • vascular associated smooth muscle cell CL0000359
    CSI 1.5
    rCSI 4.9%
    PRS 11.3%
  • skeletal muscle satellite stem cell CL0008011
    CSI 1.5
    rCSI 6.9%
    PRS 28.9%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 1.5
    rCSI 3.7%
    PRS 52.3%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [DEK](/details-gene/7913) is a proto-oncogene located on chromosome 6 that encodes a nuclear phosphoprotein with diverse roles in chromatin architecture, transcriptional regulation, and DNA repair. The DEK protein functions as a chromatin-binding factor, capable of binding both DNA and histones, and is involved in modulating chromatin structure, which influences gene expression and the maintenance of genomic integrity ([Link](https://doi.org/10.1242/jcs.115.16.3319)). **Overall**, expression data reveals that [DEK](/details-gene/7913) is a highly significant gene in progenitor and stem cell populations, particularly within the hematopoietic system, including [common myeloid progenitor cells](/details-cell/CL0000049) and [hematopoietic stem cells](/details-cell/CL0000037). Its established role in the DEK-CAN fusion protein in a subtype of acute myeloid leukemia ([Link](https://doi.org/10.1128/mcb.12.4.1687-1697.1992)) underscores its clinical relevance in oncology ([125264](https://omim.org/entry/125264)). ## Cellular Roles and Expression Landscape The expression profile of [DEK](/details-gene/7913) strongly indicates a fundamental role in maintaining cellular proliferation and pluripotency, particularly within the hematopoietic lineage. **Overall**, the gene exhibits its highest significance in a cascade of progenitor cells, including [common myeloid progenitor](/details-cell/CL0000049) (CSI: 94.59), [granulocyte monocyte progenitor cell](/details-cell/CL0000557) (CSI: 93.55), [hematopoietic stem cell](/details-cell/CL0000037) (CSI: 93.39), and [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 90.50). This pattern extends to lymphoid progenitors, such as the [pro-B cell](/details-cell/CL0000826), and other highly proliferative, non-hematopoietic cell types like [keratinocytes](/details-cell/CL0000312) and [transit amplifying cells of the colon](/details-cell/CL0009011). Conversely, [DEK](/details-gene/7913) shows significantly low expression in terminally differentiated and post-mitotic cells. Its status as an anti-marker in cell types such as [astrocyte of the cerebral cortex](/details-cell/CL0002605) (CSI: -10.40), [regular ventricular cardiac myocyte](/details-cell/CL0002131) (CSI: -3.33), and [cardiac neuron](/details-cell/CL0010022) (CSI: -4.12) suggests that its downregulation is associated with cellular maturation and exit from the cell cycle. This dichotomy highlights a specialized role for [DEK](/details-gene/7913) in regulating the biology of undifferentiated and rapidly dividing cells, rather than in the homeostatic functions of mature tissues. ## Pathways and Molecular Function The molecular functions of [DEK](/details-gene/7913) are intrinsically linked to the regulation of nuclear processes, which is consistent with its primary localization in the [nucleus](/details-gene/GO:0005634) and [nucleolus](/details-gene/GO:0005730). Its annotation for '[Chromatin remodeling](/details-gene/GO:0006338)' and '[Histone binding](/details-gene/GO:0042393)' provides a mechanistic basis for its influence on gene expression programs. This is further specified by its involvement in the positive regulation of transcription by all three major RNA polymerases, including '[Positive regulation of transcription by rna polymerase ii](/details-gene/GO:0045944)'. Its role in the hematopoietic system is strongly supported by its participation in the '[Transcriptional regulation of granulopoiesis](/details-gene/R-HSA-9616222)' pathway, which aligns with its high CSI scores in myeloid progenitors. Furthermore, [DEK](/details-gene/7913) is a component of the '[B-wich complex](/details-gene/GO:0110016)', which is involved in the '[Positive epigenetic regulation of rrna expression](/details-gene/R-HSA-5250913)'. The upregulation of rRNA synthesis is a critical requirement for ribosome biogenesis and protein synthesis, essential for the growth and proliferation of progenitor cells. Additionally, its function in '[Regulation of double-strand break repair](/details-gene/GO:2000779)' suggests a critical role in maintaining genomic stability, a vital process for stem cells that undergo frequent division. ## Research Directions The data positions [DEK](/details-gene/7913) as a key regulator of progenitor cell biology with direct implications for hematological malignancies. Based on its expression pattern and known functions, several testable hypotheses can be proposed: 1. **Hypothesis on Leukemic Transformation:** Dysregulation or overexpression of [DEK](/details-gene/7913) in hematopoietic progenitors may contribute to leukemogenesis by blocking terminal differentiation and promoting a state of uncontrolled self-renewal. This is consistent with its identity as a proto-oncogene and its involvement in the DEK-CAN fusion protein in AML ([Link](https://doi.org/10.1128/mcb.12.4.1687-1697.1992)). 2. **Hypothesis on Genomic Stability:** The involvement of [DEK](/details-gene/7913) in '[Regulation of double-strand break repair via nonhomologous end joining](/details-gene/GO:2001032)' suggests it is critical for safeguarding the genome of rapidly dividing progenitor cells. Its functional impairment could lead to genomic instability, a hallmark of cancer, thereby predisposing cells to malignant transformation. To test the first hypothesis regarding the role of [DEK](/details-gene/7913) in differentiation arrest, a key experiment could involve the use of CRISPR-Cas9 to knock out [DEK](/details-gene/7913) in primary human [hematopoietic stem and progenitor cells](/details-cell/CL0000037). These modified cells could then be cultured in vitro under conditions that promote myeloid differentiation. The progression of differentiation could be monitored over time using flow cytometry to quantify cell surface markers for mature granulocytes and monocytes, alongside colony-forming unit (CFU) assays to assess lineage potential. A corresponding gain-of-function experiment involving lentiviral overexpression of [DEK](/details-gene/7913) would complement this analysis. RNA-sequencing of these manipulated progenitor populations would reveal the downstream transcriptional programs controlled by [DEK](/details-gene/7913) that govern the balance between self-renewal and differentiation. Given its role as a proto-oncogene and its overexpression in certain cancers, [DEK](/details-gene/7913) represents a potential therapeutic target. A strategy of **inhibition** would be appropriate. Because [DEK](/details-gene/7913) is an intracellular chromatin-associated protein without enzymatic activity, it represents a challenging target for traditional small molecule inhibitors. However, developing strategies to disrupt its interaction with other key chromatin proteins or targeting the specific DEK-CAN fusion protein in relevant leukemia subtypes could offer more promising therapeutic avenues.

Genular Protein ID: 1451792518

Symbol: DEK_HUMAN

Name: Protein DEK

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 1549122

Title: The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.

PubMed ID: 1549122

DOI: 10.1128/mcb.12.4.1687-1697.1992

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 14574404

Title: The DNA sequence and analysis of human chromosome 6.

PubMed ID: 14574404

DOI: 10.1038/nature02055

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11118221

Title: The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions.

PubMed ID: 11118221

DOI: 10.1093/emboj/19.24.6860

PubMed ID: 12140263

Title: Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek.

PubMed ID: 12140263

DOI: 10.1242/jcs.115.16.3319

PubMed ID: 15199154

Title: Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.

PubMed ID: 15199154

DOI: 10.1128/mcb.24.13.6011-6020.2004

PubMed ID: 17081983

Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

PubMed ID: 17081983

DOI: 10.1016/j.cell.2006.09.026

PubMed ID: 16603771

Title: The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription.

PubMed ID: 16603771

DOI: 10.1074/jbc.m600233200

PubMed ID: 17524367

Title: The distribution of the DEK protein in mammalian chromatin.

PubMed ID: 17524367

DOI: 10.1016/j.bbrc.2007.05.019

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 18318008

Title: Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.

PubMed ID: 18318008

DOI: 10.1002/pmic.200700884

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19695025

Title: Proteome analysis of human nuclear insoluble fractions.

PubMed ID: 19695025

DOI: 10.1111/j.1365-2443.2009.01324.x

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 28190768

Title: Serine ADP-ribosylation depends on HPF1.

PubMed ID: 28190768

DOI: 10.1016/j.molcel.2017.01.003

PubMed ID: 15238633

Title: Solution NMR structure of the C-terminal domain of the human protein DEK.

PubMed ID: 15238633

DOI: 10.1110/ps.04797104

PubMed ID: 18227428

Title: Solution NMR structure of the N-terminal domain of the human DEK protein.

PubMed ID: 18227428

DOI: 10.1110/ps.073244108

Sequence Information:

  • Length: 375
  • Mass: 42674
  • Checksum: C07D22B37B719A23
  • Sequence:
  • MSASAPAAEG EGTPTQPASE KEPEMPGPRE ESEEEEDEDD EEEEEEEKEK SLIVEGKREK 
    KKVERLTMQV SSLQREPFTI AQGKGQKLCE IERIHFFLSK KKTDELRNLH KLLYNRPGTV 
    SSLKKNVGQF SGFPFEKGSV QYKKKEEMLK KFRNAMLKSI CEVLDLERSG VNSELVKRIL 
    NFLMHPKPSG KPLPKSKKTC SKGSKKERNS SGMARKAKRT KCPEILSDES SSDEDEKKNK 
    EESSDDEDKE SEEEPPKKTA KREKPKQKAT SKSKKSVKSA NVKKADSSTT KKNQNSSKKE 
    SESEDSSDDE PLIKKLKKPP TDEELKETIK KLLASANLEE VTMKQICKKV YENYPTYDLT 
    ERKDFIKTTV KELIS